Study on non-programmed process using dimethyl sulfoxide and hydroxyethyl starch as cryoprotectants in cryopreservation of cord blood hematopoietic cells.
- Author:
Kai-Yan LIU
1
;
Wen-Chuan DONG
;
Yi-Lan WANG
;
Yong-Jun JIANG
;
Zhi-Yong GAO
;
Ning-Wei HUANG
;
Dao-Pei LU
Author Information
1. People Hospital, Institute of Hematology, Peking University, Beijing 100044, China. kaiyanliu@mail.china.com
- Publication Type:Journal Article
- MeSH:
Cryopreservation;
Cryoprotective Agents;
pharmacology;
Dimethyl Sulfoxide;
pharmacology;
Fetal Blood;
cytology;
Hematopoietic Stem Cells;
cytology;
Humans;
Hydroxyethyl Starch Derivatives;
pharmacology
- From:
Journal of Experimental Hematology
2004;12(5):670-673
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to search for effective cryoprotectants and freezing methods used in cord blood bank (CBB) for cryopreservation of cord blood hematopoietic stem cells. The non-programmed group using 8% final concentration of dimethyl sulfoxide (DMSO) and 5% final concentration hydroxyethyl starch (HES) (molecular weight 120,000) as protectants and group of conventional of programmed controller method using 10% DMSO only as cryoprotectant in cryopreservation of cord blood hematopoietic stem cells were compared. In each of the two groups, 15 cord blood units were used. In non-programmed group, cord blood units put in -80 degrees C refrigerator for 24 hours as a transitional step before deep-freezing in liquid nitrogen, when both of DMSO and HES had been added. The recoveries of the nuclear cells number, the yield of granulocyto-macrophage colony forming units (CFU-GM) and the cells viability in cord blood units before preservation and after thawing were tested for both methods. The results showed that no significant difference was found in above assays between two groups. The clinical application results also showed that hematopoietic engraftment rates after infusion were similar in both groups. It is concluded that the non-programmed method by -80 degrees C refrigerator as a transitional step and using the combined two protectants seems simple in operation and effective in clinical transplantation as well as the conventional programmed method.
